463.43

0.12% -0.57

Alnylam Pharmaceuticals Inc (ALNY)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché ALNY Giù? Forum Previsione

Precedente Chiudi:

$464.00

Aprire:

$468.68

Volume 24 ore:

771.27K

Relative Volume:

0.66

Capitalizzazione di mercato:

$60.75B

Reddito:

$2.46B

Utile/perdita netta:

$-319.09M

Rapporto P/E:

-187.86

EPS:

-2.4669

Flusso di cassa netto:

$-52.09M

1 W Prestazione:

-3.79%

1M Prestazione:

+1.10%

6M Prestazione:

+91.02%

1 anno Prestazione:

+57.80%

Intervallo 1D:

$459.38

$469.29

Intervallo di 1 settimana:

$456.90

$495.55

Portata 52W:

$205.87

$495.55

Alnylam Pharmaceuticals Inc Stock (ALNY) Company Profile

Nome

Alnylam Pharmaceuticals Inc

Settore

Healthcare (1140)

Industria

Biotechnology (637)

Telefono

(617) 551-8200

Indirizzo

675 WEST KENDALL STREET, CAMBRIDGE, MA

Dipendente

2,230

Cinguettio

@alnylam

Prossima data di guadagno

2024-10-31

Ultimi documenti SEC

ALNY's Discussions on Twitter

Confronta ALNY con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
ALNY Alnylam Pharmaceuticals Inc	463.43	60.82B	2.46B	-319.09M	-52.09M	-2.4669
VRTX Vertex Pharmaceuticals Inc	421.39	108.36B	11.39B	3.64B	3.50B	13.99
REGN Regeneron Pharmaceuticals Inc	577.95	61.02B	14.21B	4.46B	3.56B	39.69
ARGX Argen X Se Adr	817.32	50.01B	3.06B	1.28B	447.35M	19.67
ONC Beone Medicines Ltd Adr	310.81	34.05B	4.56B	-176.77M	225.30M	-1.7177

Alnylam Pharmaceuticals Inc Stock (ALNY) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-08-04	Aggiornamento	Oppenheimer	Perform → Outperform
2025-08-04	Aggiornamento	Wolfe Research	Underperform → Peer Perform
2025-07-30	Ripresa	Raymond James	Outperform
2025-07-21	Iniziato	Truist	Buy
2025-03-31	Iniziato	Redburn Atlantic	Buy
2025-03-24	Aggiornamento	JP Morgan	Neutral → Overweight
2024-11-12	Downgrade	Wolfe Research	Peer Perform → Underperform
2024-10-16	Iniziato	Scotiabank	Sector Outperform
2024-08-16	Aggiornamento	Goldman	Neutral → Buy
2024-02-16	Downgrade	Goldman	Buy → Neutral
2024-02-15	Iniziato	Wolfe Research	Peer Perform
2023-12-08	Iniziato	Wells Fargo	Equal Weight
2023-10-11	Downgrade	Oppenheimer	Outperform → Perform
2023-09-29	Iniziato	Raymond James	Outperform
2023-05-05	Aggiornamento	BMO Capital Markets	Market Perform → Outperform
2023-04-26	Iniziato	SMBC Nikko	Neutral
2023-03-21	Iniziato	Bernstein	Outperform
2023-01-18	Iniziato	Canaccord Genuity	Buy
2022-09-09	Ripresa	Morgan Stanley	Equal-Weight
2022-07-13	Iniziato	Cantor Fitzgerald	Neutral
2022-06-27	Downgrade	Guggenheim	Buy → Neutral
2022-06-07	Iniziato	William Blair	Outperform
2022-04-25	Downgrade	Morgan Stanley	Overweight → Equal-Weight
2022-03-01	Iniziato	Citigroup	Buy
2022-02-03	Aggiornamento	Guggenheim	Neutral → Buy
2022-01-03	Aggiornamento	Piper Sandler	Neutral → Overweight
2021-11-22	Aggiornamento	Goldman	Neutral → Buy
2021-11-22	Aggiornamento	RBC Capital Mkts	Sector Perform → Outperform
2021-11-01	Aggiornamento	Oppenheimer	Perform → Outperform
2021-10-04	Aggiornamento	UBS	Neutral → Buy
2021-08-04	Downgrade	Piper Sandler	Overweight → Neutral
2021-02-22	Downgrade	Guggenheim	Buy → Neutral
2021-02-12	Downgrade	Citigroup	Buy → Neutral
2021-02-12	Reiterato	H.C. Wainwright	Buy
2021-01-25	Downgrade	BMO Capital Markets	Outperform → Market Perform
2020-09-30	Ripresa	Berenberg	Hold
2020-09-08	Iniziato	Citigroup	Buy
2020-08-11	Downgrade	Oppenheimer	Outperform → Perform
2020-05-13	Iniziato	RBC Capital Mkts	Sector Perform
2020-05-07	Downgrade	JP Morgan	Overweight → Neutral
2020-04-24	Ripresa	Evercore ISI	Outperform
2020-03-19	Iniziato	Berenberg	Buy
2019-12-19	Reiterato	Chardan Capital Markets	Buy
2019-11-20	Iniziato	Oppenheimer	Outperform
2019-11-13	Iniziato	BofA/Merrill	Buy
2019-05-23	Ripresa	Goldman	Neutral
2019-04-12	Iniziato	Evercore ISI	Outperform
2019-03-06	Aggiornamento	Evercore ISI	In-line → Outperform
2019-03-05	Aggiornamento	Morgan Stanley	Equal-Weight → Overweight
2019-01-23	Iniziato	UBS	Neutral
2018-10-01	Iniziato	Cantor Fitzgerald	Overweight
2018-08-13	Reiterato	Stifel	Buy
2018-08-07	Aggiornamento	Stifel	Hold → Buy
2018-05-04	Reiterato	Stifel	Hold
2018-03-28	Iniziato	Evercore ISI	In-line

Mostra tutto

Alnylam Pharmaceuticals Inc Borsa (ALNY) Ultime notizie

09:38 AM

Why Alnylam Pharmaceuticals Inc. stock is recommended by analysts2025 Earnings Surprises & Risk Adjusted Buy/Sell Alerts - newser.com

09:38 AM

08:12 AM

Is Alnylam Pharmaceuticals Inc. (DUL) stock vulnerable to rate hikes2025 Price Momentum & Consistent Growth Stock Picks - newser.com

08:12 AM

07:53 AM

Has Alnylam Pharmaceuticals Inc. found a price floorInflation Watch & Technical Pattern Based Buy Signals - newser.com

07:53 AM

04:56 AM

What downside risks could hit Alnylam Pharmaceuticals Inc. (DUL) stockJuly 2025 Momentum & Accurate Trade Setup Notifications - newser.com

04:56 AM

04:48 AM

Is Alnylam Pharmaceuticals Inc. stock resilient to inflation2025 Sector Review & Safe Entry Zone Tips - newser.com

04:48 AM

04:31 AM

Is Alnylam Pharmaceuticals Inc. (DUL) stock overpriced at current multiplesWeekly Profit Report & Long-Term Capital Growth Ideas - newser.com

04:31 AM

02:14 AM

Is it time to cut losses on Alnylam Pharmaceuticals Inc.Trade Exit Report & Advanced Swing Trade Entry Plans - newser.com

02:14 AM

Oct 24, 2025

Using data filters to optimize entry into Alnylam Pharmaceuticals Inc.2025 Risk Factors & AI Powered Market Entry Strategies - newser.com

Oct 24, 2025

How to recover losses in Alnylam Pharmaceuticals Inc. stockWall Street Watch & Long-Term Capital Growth Ideas - newser.com

Oct 24, 2025

Oct 23, 2025

Alnylam Pharmaceuticals (ALNY) Earnings Expected to Grow: What to Know Ahead of Next Week's Release - Yahoo Finance

Oct 23, 2025

Oct 22, 2025

Custom watchlist performance reports with Alnylam Pharmaceuticals Inc.2025 Market Outlook & Daily Stock Momentum Reports - newser.com

Oct 22, 2025

Oct 21, 2025

Published on: 2025-10-21 18:00:20 - newser.com

Oct 21, 2025

Published on: 2025-10-21 15:17:29 - newser.com

Oct 21, 2025

Are Alnylam Shares Still Attractive After a 110% Surge and Fresh Pipeline News? - simplywall.st

Oct 21, 2025